Perosphere Technologies

Perosphere Technologies, as a private medical technology company, is committed to the development and commercialization of its novel PoC (Point-of-Care) coagulation analyzer. This device provides precise data for diagnosis, treatment, and prevention, accessible to everyone immediately. It is the only point-of-care diagnostic tool capable of effectively and rapidly testing clotting times for various drugs, including DOACs. The rapid diagnosis enabled by the PoC coagulation analyzer, along with associated appropriate treatment decisions, will help establish new care standards for high bleeding-risk patients in hospital emergency departments. It also has the potential to improve efficiency, reduce costs, and enhance patient outcomes. The PoC coagulation analyzer has received EU CE certification but has not yet been approved in the United States.